Merit Medical Systems (MMSI) EBITDA (2010 - 2026)

Merit Medical Systems' EBITDA history runs 17 years deep, the most recent figure standing at $44.2 million for Q1 2026.

• In Q1 2026, EBITDA rose 7.61% year-over-year to $44.2 million; the TTM figure through Mar 2026 stood at $39.0 million (up 6.59% YoY), while the FY2025 annual figure was $35.9 million, up 13.96% from the prior year.
• EBITDA came in at $44.2 million for Q1 2026 at Merit Medical Systems, up from -$94.6 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $46.9 million in Q2 2025 to a low of -$94.6 million in Q4 2025.
• A 5-year average of $13.1 million and a median of $30.4 million in 2022 frame the typical range for EBITDA.
• Across the five-year window, EBITDA surged 161.45% in 2022 and slumped 319.59% in 2023, its largest moves.
• Merit Medical Systems' EBITDA stood at $30.4 million in 2022, then tumbled by 319.59% to -$66.8 million in 2023, then slumped by 31.2% to -$87.6 million in 2024, then retreated by 7.99% to -$94.6 million in 2025, then soared by 146.66% to $44.2 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $44.2 million, -$94.6 million, and $42.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison